We are live on ! Find out more
Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT) Portfolio holdings

AUM $89.9B
1-Year Est. Return 20.22%
This Fund
S&P 500
This Quarter Est. Return
+2.75%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
AUM
$27.5B
AUM Growth
+$4.26B
Cap. Flow
+$26B
Cap. Flow %
94.62%
Top 10 Hldgs %
8.07%
Holding
3,226
New
745
Increased
868
Reduced
662
Closed
894

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$151M
2
JNJ icon
Johnson & Johnson
JNJ
+$149M
3
COP icon
ConocoPhillips
COP
+$142M
4
DHR icon
Danaher
DHR
+$112M
5
SPGI icon
S&P Global
SPGI
+$106M

Sector Composition

Rank Sector Weight
1 Technology 21.09%
2 Consumer Discretionary 14.55%
3 Financials 12.04%
4 Healthcare 11.32%
5 Industrials 10.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARDC
1701
Are Dynamic Credit Allocation Fund
ARDC
$296M
$262K ﹤0.01%
21,211
CTRN icon
1702
Citi Trends
CTRN
$543M
$261K ﹤0.01%
+14,799
New +$255K
AEHR icon
1703
Aehr Test Systems
AEHR
$2.52B
$261K ﹤0.01%
6,335
-54,464
-90% -$1.79M
HTO
1704
H2O America
HTO
$2.66B
$260K ﹤0.01%
+3,711
New +$280K
NIC icon
1705
Nicolet Bankshares
NIC
$3.54B
$260K ﹤0.01%
3,825
-6,153
-62% -$390K
UEIC icon
1706
Universal Electronics
UEIC
$57.6M
$255K ﹤0.01%
+26,461
New +$245K
SCHA icon
1707
Schwab U.S Small- Cap ETF
SCHA
$22.4B
$254K ﹤0.01%
+15,294
New +$319K
CTBI icon
1708
Community Trust Bancorp
CTBI
$1.39B
$254K ﹤0.01%
7,132
-3,916
-35% -$141K
CRSP icon
1709
CRISPR Therapeutics
CRSP
$4.6B
$253K ﹤0.01%
+4,506
New +$256K
SLCA
1710
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$252K ﹤0.01%
+20,796
New +$257K
VRTS icon
1711
Virtus Investment Partners
VRTS
$1.12B
$252K ﹤0.01%
+1,275
New +$241K
DGS icon
1712
WisdomTree Emerging Markets SmallCap Dividend Fund
DGS
$1.71B
$252K ﹤0.01%
3,773
+1,835
+95% +$85.2K
IIPR icon
1713
Innovative Industrial Properties
IIPR
$1.78B
$251K ﹤0.01%
+3,434
New +$242K
PYCR
1714
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
$249K ﹤0.01%
+10,531
New +$246K
MORN icon
1715
Morningstar
MORN
$6.94B
$248K ﹤0.01%
1,265
-12,334
-91% -$2.44M
PNT
1716
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$248K ﹤0.01%
+27,357
New +$241K
BLDR icon
1717
Builders FirstSource
BLDR
$7.82B
$248K ﹤0.01%
1,821
-143,518
-99% -$16M
ICF icon
1718
iShares Select U.S. REIT ETF
ICF
$2.12B
$247K ﹤0.01%
4,789
+4,086
+581% +$222K
BELFB
1719
Bel Fuse Inc Class B
BELFB
$3.84B
$247K ﹤0.01%
4,298
-18,962
-82% -$868K
IWD icon
1720
iShares Russell 1000 Value ETF
IWD
$81.5B
$247K ﹤0.01%
3,287
-87,183
-96% -$13.3M
TVRD
1721
Tvardi Therapeutics
TVRD
$23.8M
$246K ﹤0.01%
2,410
+1,989
+472% +$274K
MCS icon
1722
Marcus Corp
MCS
$752M
$244K ﹤0.01%
+16,437
New +$266K
GRWG icon
1723
GrowGeneration
GRWG
$88.9M
$243K ﹤0.01%
71,476
-160,129
-69% -$567K
SAR icon
1724
Saratoga Investment
SAR
$316M
$243K ﹤0.01%
+8,991
New +$231K
AHT
1725
Ashford Hospitality Trust
AHT
$20.9M
$242K ﹤0.01%
+6,484
New +$244K

Similar funds

Qube Research & Technologies (QRT)'s Q2 2023 Portfolio in Review

As of Q2 2023, Qube Research & Technologies (QRT) held 3,226 positions worth $27.5B, up 18% from $23.2B the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.

Qube Research & Technologies (QRT) deployed $26B of net new capital in Q2 2023, opening 745 new positions and adding to 868 existing holdings. Its largest new stake was Microsoft: 704,526 shares worth $240M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Cigna, an estimated $151M trimmed.

  • Qube Research & Technologies (QRT)'s largest Q2 2023 buy was Microsoft: 704,526 shares worth $240M.
  • Qube Research & Technologies (QRT) added most to Thermo Fisher Scientific in Q2 2023, an estimated $192M increase.
  • Qube Research & Technologies (QRT)'s biggest Q2 2023 reduction was Cigna, cutting an estimated $151M.
  • Qube Research & Technologies (QRT) fully exited ConocoPhillips in Q2 2023, selling an estimated $142M.
  • Qube Research & Technologies (QRT)'s ten largest holdings make up 8.1% of its $27.5B portfolio in Q2 2023.
  • Qube Research & Technologies (QRT) opened 745 new positions and closed 894 in Q2 2023.
  • Qube Research & Technologies (QRT)'s portfolio value rose 18% quarter-over-quarter to $27.5B.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2023, filed 14 Aug 2023.